Amneal Industry-Sponsored Breakfast Session

Thursday, 8 May – 07:00-08:00

Innovation and outcomes: A case-based perspective on CREXONT® (carbidopa and levodopa) extended-release capsules

Robert Hauser

Dr. Robert Hauser

Daniel Kremens

Dr. Daniel Kremens

Join Dr. Robert Hauser and Dr. Daniel Kremens to learn more about the clinical efficacy and safety profile of CREXONT, guidance on initiating dosing, and insights from their experiences in clinical practice.